Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin in Addition to Empagliflozin in T2DM
NCT02401880Phase 4Completed
- Sponsor
- Profil
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Profil. Started May 2015; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02401880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401880.